TEL AVIV, Israel--(BUSINESS WIRE)--Vectorious Medical Technologies Ltd., an innovator in implantable hemodynamic monitoring in heart failure (HF), today announced results of VECTOR-HF I, a ...
REGENX Biosciences, LLC today announced that gene transfer mediated by REGENX's NAV® AAV9 vector can be accomplished in vivo and globally correct central nervous system (CNS) manifestations of MPS I, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback